Lumos Pharma Inc (LUMO)
Market Closed
11 Dec, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
4. 34
0
0%
$
37.54M Market Cap
- P/E Ratio
- Div Yield
390,873 Volume
-4.15 Eps
$ 4.34
Previous Close Want to track LUMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LUMO Earnings Reports FAQ
What is the earnings per share (EPS) for LUMO?
The current EPS is -4.15.
What is the company's earnings growth rate?
Lumos Pharma Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lumos Pharma Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lumos Pharma Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LUMO at this time, as Lumos Pharma Inc has no recent EPS data to calculate it.
